Literature DB >> 24493506

Trends in the prevalence of asthma.

Malcolm R Sears1.   

Abstract

The asthma epidemic of the last few decades may have peaked; studies suggest that the incidence and prevalence of asthma has decreased in some countries in the last few years, although other studies suggest continuing small increases in prevalence. Increasing awareness and changing diagnostic habits make precise evaluation of epidemiologic trends difficult in the absence of a gold-standard test for asthma, and on a global basis uncertainty persists. Trends in prevalence in some populations (eg, immigrants, farming communities) suggest both adverse and beneficial effects of specific environmental factors. Although the effects of indoor allergens, dampness, and mold and of outdoor air pollutants, especially traffic related, have traditionally dominated risk-factor research, more recent epidemiologic and clinical studies have focused on metabolic and nutritional factors, including maternal obesity and vitamin D levels, mode of delivery and its effect on the infant microbiome, fetal and infant growth, the psychosocial environment, and medication use by mother and infant. It is likely that changes in incidence and prevalence are due to multiple factors, each contributing a relatively small effect. Longitudinal studies from pregnancy through childhood to adulthood will yield greater insights into the complex pathways leading to asthma.

Entities:  

Mesh:

Year:  2014        PMID: 24493506     DOI: 10.1378/chest.13-2059

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  33 in total

1.  Inhalation of the reactive aldehyde acrolein promotes antigen sensitization to ovalbumin and enhances neutrophilic inflammation.

Authors:  Edmund O'Brien; Page C Spiess; Aida Habibovic; Milena Hristova; Robert A Bauer; Matthew J Randall; Matthew E Poynter; Albert van der Vliet
Journal:  J Immunotoxicol       Date:  2015-04-15       Impact factor: 3.000

Review 2.  Severe asthma: definition, diagnosis and treatment.

Authors:  Marek Lommatzsch; J Christian Virchow
Journal:  Dtsch Arztebl Int       Date:  2014-12-12       Impact factor: 5.594

3.  Regulation of IL-17A and implications for TGF-β1 comodulation of airway smooth muscle remodeling in severe asthma.

Authors:  Jon M Evasovic; Cherie A Singer
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-02-27       Impact factor: 5.464

4.  Asthma, Chronic Obstructive Pulmonary Disease, and Subsequent Risk for Incident Rheumatoid Arthritis Among Women: A Prospective Cohort Study.

Authors:  Julia A Ford; Xinyi Liu; Su H Chu; Bing Lu; Michael H Cho; Edwin K Silverman; Karen H Costenbader; Carlos A Camargo; Jeffrey A Sparks
Journal:  Arthritis Rheumatol       Date:  2020-04-03       Impact factor: 10.995

5.  IL-33trap is a novel IL-33-neutralizing biologic that inhibits allergic airway inflammation.

Authors:  Aurora Holgado; Harald Braun; Elien Van Nuffel; Sammy Detry; Martijn J Schuijs; Kim Deswarte; Karl Vergote; Mira Haegman; Griet Baudelet; Jurgen Haustraete; Hamida Hammad; Bart N Lambrecht; Savvas N Savvides; Inna S Afonina; Rudi Beyaert
Journal:  J Allergy Clin Immunol       Date:  2019-03-13       Impact factor: 10.793

Review 6.  Helicobacter pylori update: gastric cancer, reliable therapy, and possible benefits.

Authors:  David Y Graham
Journal:  Gastroenterology       Date:  2015-02-02       Impact factor: 22.682

7.  Aeroallergen sensitivity in Hawai'i: association with asthma and increased prevalence of sensitivity to indoor allergens since 1966.

Authors:  Kathleen Min; Marianne Yoshida; Rei Miike; Elizabeth Tam
Journal:  Hawaii J Med Public Health       Date:  2014-09

8.  Effect of early and late prenatal vitamin D and maternal asthma status on offspring asthma or recurrent wheeze.

Authors:  Mengdi Lu; Augusto A Litonjua; George T O'Connor; Robert S Zeiger; Leonard Bacharier; Michael Schatz; Vincent J Carey; Scott T Weiss; Hooman Mirzakhani
Journal:  J Allergy Clin Immunol       Date:  2020-08-19       Impact factor: 10.793

9.  Expression levels of plasma exosomal miR-124, miR-125b, miR-133b, miR-130a and miR-125b-1-3p in severe asthma patients and normal individuals with emphasis on inflammatory factors.

Authors:  Mostafa Atashbasteh; Esmaeil Mortaz; Seyed Alireza Mahdaviani; Hamidreza Jamaati; Abdolamir Allameh
Journal:  Allergy Asthma Clin Immunol       Date:  2021-05-17       Impact factor: 3.406

10.  Asthma Medication Use and Risk of Birth Defects: National Birth Defects Prevention Study, 1997-2011.

Authors:  Meredith M Howley; Eleni A Papadopoulos; Carla M Van Bennekom; Alissa R Van Zutphen; Suzan L Carmichael; JeanPierre W Munsie; Michele L Herdt; Marilyn L Browne
Journal:  J Allergy Clin Immunol Pract       Date:  2020-07-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.